Table 2 Body-weight (g) measurement in CD2F1 mice after IL-18BP or vehicle treatment.

From: IL-18 binding protein (IL-18BP) as a novel radiation countermeasure after radiation exposure in mice

Treatment

Pre-injection

D1

D2

D3

D4

D7

D9

D11

D14

Vehicle

28.7 ± 0.9

28.4 ± 1.0

28.3 ± 1.3

28.0 ± 1.0

28.3 ± 1.0

28.6 ± 0.7

28.8 ± 0.9

29.2 ± 1.0

28.8 ± 1.0

IL-18BP

0.25 mg/kg

28.4 ± 3.8

28.1 ± 3.5

28.3 ± 3.7

28.4 ± 3.7

28.7 ± 3.8

29.1 ± 3.8

29.1 ± 4.0

29.9 ± 4.2

29.5 ± 4.2

0.5 mg/kg

27.1 ± 1.3

26.7 ± 1.5

26.4 ± 1.3

26.5 ± 1.3

27.4 ± 1.3

27.5 ± 1.5

27.3 ± 1.6

28.0 ± 1.7

28.9 ± 1.7

1.0 mg/kg

28.5 ± 1.8

28.4 ± 2.0

27.9 ± 2.0

27.9 ± 2.0

28.0 ± 2.0

28.2 ± 1.8

28.6 ± 1.9

28.6 ± 1.9

28.7 ± 1.8

1.5 mg/kg

28.4 ± 2.0

28.0 ± 2.1

28.0 ± 2.0

28.1 ± 1.7

28.5 ± 1.9

28.6 ± 1.6

28.7 ± 1.6

29.0 ± 1.5

29.0 ± 1.4

2.0 mg/kg

29.2 ± 1.6

29.2 ± 1.6

29.0 ± 1.6

29.0 ± 1.8

29.5 ± 1.8

29.6 ± 2.0

29.7 ± 2.1

30.1 ± 2.1

29.9 ± 2.2

3.0 mg/kg

29.1 ± 1.3

29.3 ± 1.5

28.9 ± 1.4

28.5 ± 1.4

29.3 ± 0.7

28.5 ± 1.4

28.9 ± 1.6

29.1 ± 1.5

29.2 ± 1.8

5.0 mg/kg

29.2 ± 1.6

29.0 ± 1.8

28.8 ± 1.7

28.5 ± 1.8

29.2 ± 1.2

28.5 ± 1.7

28.8 ± 1.7

29.2 ± 1.6

29.3 ± 1.8

  1. Subcutaneous injection, no significant body weight changes before and after treatment with either IL-18BP or vehicle (N = 6).